My first focus is seeing this get to a valuation it deserves between $750m-$1b before we get to the next trial and any designation. We'll have that valuation and, well before we get a seriously considered merger/takeover.
At roughly $260m market value now, we're still cheap in comparison and in our own right.
A new sub position is what I'd like to see to propel us there short term.
- Forums
- ASX - By Stock
- AVR
- Takeover : pool your guesses !
Takeover : pool your guesses !, page-15
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.81 |
Change
-0.190(1.90%) |
Mkt cap ! $209.4M |
Open | High | Low | Value | Volume |
$10.00 | $10.00 | $9.65 | $52.59K | 5.353K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 499 | $9.77 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.84 | 2 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 499 | 9.770 |
1 | 150 | 9.760 |
1 | 180 | 9.750 |
1 | 180 | 9.740 |
1 | 180 | 9.730 |
Price($) | Vol. | No. |
---|---|---|
9.840 | 2 | 1 |
9.910 | 476 | 2 |
9.990 | 265 | 2 |
10.000 | 1304 | 2 |
10.500 | 10096 | 3 |
Last trade - 15.43pm 12/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online